as follows. The total revenue of the Company and its subsidiaries in the consolidated financial statements for the year 2017 was equal to 762.85 million Baht, an increase of 148.67 million Baht or

operating performance for 31 March 2019 as the following. Key Financial Information on 31 March 2019 , 2018 (Unit : thousands) Statements of Income Separate financial statements March 31, 2019 March 31, 2018

operating performance for 30 June 2019 as the following. Key Financial Information on 30 June 2019 , 2018 (Unit : thousands) Statements of Income Separate financial statements June 30, 2019 June 30, 2018

baht. The total income was selling and administrative expense was expense was 63.57 million baht. 43,209.91 million baht and the total equity was For the Separate financial statements, the Company had

which had lost equal to 49.62 million Baht. However, for the Separate Financial Statements of the Company for the third quarter of the year 2017, the company had total revenues equivalent to 95.08 million

previous year 7.62%. Income from medical treatments in the separate financial statement went up 4.79% due to the increased in the number of out-patients to 2.57% but the decreased in the number of in

the total equity was 7,671.02 million baht. For the Separate financial statements, the Company had net profit of the fourth quarter of 2019 was 449.87 million baht. A decrease of 5.04 million baht or

% For the separate financial statements, the Company shows operation results for the six-month period ended June, 2017 with the following details: unit: THB million 2017 2016 Change (THB million) Change

due to increase of export sales. 2) Cost of sales decreased by Baht 10.80 million due to sales amount increase from selling price increasing. Cost of sales ratio at 87.54% (2017 : at 89.36%) which

to increase of export sales increased by Baht 10.95 million and local sales increased by Baht 1.45 million. 2) Cost of sales increase by Baht 4.38 million mainly from increase from employee benefit